Prescription drug · BLA
Rethymic NDC 72359-001
allogenic thymocyte-depleted thymus tissue-agdc · Allogeneic thymocyte-depleted thymus tissue-agdc 22000 mm/1 · Implant · Intramuscular · Sumitomo Pharma America, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72359-001-01 | 72359000101 | 11 CONTAINER in 1 BOX (72359-001-01) / 4 IMPLANT in 1 CONTAINER (72359-001-02)Marketed from Oct 8, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Rethymic
- Generic name (nonproprietary)
- allogenic thymocyte-depleted thymus tissue-agdc
- Active ingredients
- Allogeneic thymocyte-depleted thymus tissue-agdc — 22000 mm/1
- Dosage form
- Implant
- Route
- Intramuscular
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125685
- Marketing start
- Listing expires
- Identifiers
- Product ID 72359-001_6b1c53ef-4ff9-46ff-96ad-b0cb5609ec17SPL ID 6b1c53ef-4ff9-46ff-96ad-b0cb5609ec17SPL set ID e0022c28-8cda-4f1e-bcf1-1f440d37ec4aRxCUI 2626464, 2626469UNII XD66YK3YY3UPC 0372359001015
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472359000101followed by a unit qualifier and the quantityPackage 72359-0001-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
RETHYMIC ® is indicated for immune reconstitution in pediatric patients with congenital athymia. RETHYMIC is indicated for immune reconstitution in pediatric patients with congenital athymia. ( 1 ) Limitations of Use : RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID). Limitations of Use RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID).
Excerpt only. Read the full label for complete information.